Kwame Owusu-Edusei

8PUBLICATIONS
23CO-AUTHORS
Economic development policyPolitical economy and social changeEpidemiological modellingPacific Peoples theory of change models for healthAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 18, 2026
Delta price cost-effectiveness analysis of PCV21 vs PCV20 use in adults aged ≥65 years in Switzerland.

Muloongo Simuzingili, Andrea Favre-Bulle, Thomas Mutschler

|Apr 24, 2025
Economic evaluation of PCV21 in vaccine-naïve adults aged 19-64 years with underlying medical conditions in the United States.

Zinan Yi, Elamin H Elbasha, Kwame Owusu-Edusei

|Dec 20, 2024
Health and economic impact of the 21-valent pneumococcal conjugate vaccine (V116) for adults in Japan: a delta price approach.

Peter P Mueller, Atsushi Tajima, Kelsie Cassell

|Apr 08, 2024
Structured Literature Review to Identify Human Papillomavirus's Natural History Parameters for Dynamic Population Models of Vaccine Impacts.

Ibrahim Diakite, Bruno Martins, Kwame Owusu-Edusei

|Jul 29, 2023
Cost-Effectiveness of Pneumococcal Vaccination in Adults in Italy: Comparing New Alternatives and Exploring the Role of GMT Ratios in Informing Vaccine Effectiveness.

Vincenzo Restivo, Vincenzo Baldo, Laura Sticchi

|Jan 21, 2023
Cost-Effectiveness Analysis of Routine Use of 15-Valent Pneumococcal Conjugate Vaccine in the US Pediatric Population.

Min Huang, Tianyan Hu, Jessica Weaver

Pageof 2

Frequent Collaborators

3 joint publications

Elamin H Elbasha

2 joint publications

Zinan Yi

1 joint publications

Suzanne M Marks

1 joint publications

Adam J Langer